Prognosis in Ulcerative Colitis for Risk of Cancer Research Paper

Exclusively available on Available only on IvyPanda® Made by Human No AI

Eaden et al. (2001) conducted a meta-analysis of the researches that had been carried out on the topic of the probability of developing colon cancer as a continuation of ulcerative colitis. Given the fact that the results of different analyses differed greatly the aim of the authors was to remove the biases and get as precise data as possible.

In their initial collecting of the available studies they found 194 studies of which they had to disregard 78 for the reasons such as reporting the cancer mortality data, including other diseases and not including background information (Eaden et al., 2001, p. 527). After that the attempt was to extract the information about incidence of colon cancer in populations previously diagnosed with ulcerative colitis, to check whether the cancer risk increased with the duration of disease and finally to investigate the impact of colectomy on the cancer risk.

The results obtained this way yielded much more certain information about the cancer risk in those populations. The overall risk of developing colon cancer once diagnosed with ulcerative colitis was established to be 3.7%. The increase of risk was noticed at ten year intervals. During the first ten years incidence is 2%, at twenty years the risk was determined to be 8% and at thirty years about 18% which represents a serious increase.

It was also established that the incidence of colon cancer in populations with ulcerative colitis varies geographically and that the highest incidence is in the US which is closely followed by UK and Scandinavian countries are least at risk. The attempts are made at explaining this fact by differences in diet but also various differences in dealing with cancer patients in terms of referral centers (Eaden et al., 2001, p. 533).

The final note which is particularly important for this purpose is that higher rate of colectomy did not, in fact, reduce incidence of cancer, it rather increased it. However, the authors concede that the increase might be a consequence of the fact that some centers which decide on surgery more often also have more rigorous surveillance strategies (Eaden et al., 2001, p. 531).

As far as the patient in the given scenario is concerned, on the basis of the data given in (Eaden at al., 2001), one can conclude that the best solution would definitely not be prophylactic colectomy for a number of reasons and alternative methods of treatment should be considered.

First in the line of reasons for such decision is related to the fact established by the article that more colectomies in a given population did not reduce the incidence of cancer (Kewenter et al., 1978)(Dennis & Karlson, 1961). This can give enough reasons to doubt any method of treatment. In addition to that, one must consider the psychological and social consequences for an individual living life with a stoma. It seems too radical a move to decide on such an aggressive treatment with so little to gain.

Secondly, the data given in the scenario presents an opportunity to estimate the patient’s risk of developing colon cancer. The fact that she was diagnosed at the age of twenty, that is as a young adult rather than child, excludes her from the category which seems to be at the greatest risk namely patients diagnosed with ulcerative colitis as children (Michener et al. 1961). In addition, 15-year long history of disease would place a patient in the group with the cancer risk between 2 and 8 % which is definitely too little to decide on the treatment with such difficult consequences. Furthermore, additional good sign is that she has had minimal symptoms during the last five years.

I would recommend that the patient continue with regular colonoscopies and pay attention to her diet which is definitely helpful in preventing colon cancer.

References

Dennis, C., & Karlson, K. E. (1961). Cancer risk in ulcerative colitis: formidability per patient-year of late disease. Surgery, 80, 568-571.

Eaden, J. A., Abrams, K. R., & Mayberry, J. F. (2001). Risk of colorectal cancer in ulcerative colitis. Gut, 48, 526-536.

Kewenter, J., Ahlman, H., & Hulten, L. (1978). Cancer risk in extensive ulcerative colitis.. Ann Surg, 188, 824-828.

Michener, W. M., Gage, R. P., & Sauer, W. G. (1961). The prognosis of chronic ulcerative colitis in children.. N Engl J Med, 265, 1075-1079.

More related papers Related Essay Examples
Cite This paper
You're welcome to use this sample in your assignment. Be sure to cite it correctly

Reference

IvyPanda. (2022, May 3). Prognosis in Ulcerative Colitis for Risk of Cancer. https://ivypanda.com/essays/prognosis-in-ulcerative-colitis-for-risk-of-cancer/

Work Cited

"Prognosis in Ulcerative Colitis for Risk of Cancer." IvyPanda, 3 May 2022, ivypanda.com/essays/prognosis-in-ulcerative-colitis-for-risk-of-cancer/.

References

IvyPanda. (2022) 'Prognosis in Ulcerative Colitis for Risk of Cancer'. 3 May.

References

IvyPanda. 2022. "Prognosis in Ulcerative Colitis for Risk of Cancer." May 3, 2022. https://ivypanda.com/essays/prognosis-in-ulcerative-colitis-for-risk-of-cancer/.

1. IvyPanda. "Prognosis in Ulcerative Colitis for Risk of Cancer." May 3, 2022. https://ivypanda.com/essays/prognosis-in-ulcerative-colitis-for-risk-of-cancer/.


Bibliography


IvyPanda. "Prognosis in Ulcerative Colitis for Risk of Cancer." May 3, 2022. https://ivypanda.com/essays/prognosis-in-ulcerative-colitis-for-risk-of-cancer/.

If, for any reason, you believe that this content should not be published on our website, please request its removal.
Updated:
This academic paper example has been carefully picked, checked and refined by our editorial team.
No AI was involved: only quilified experts contributed.
You are free to use it for the following purposes:
  • To find inspiration for your paper and overcome writer’s block
  • As a source of information (ensure proper referencing)
  • As a template for you assignment
Privacy Settings

IvyPanda uses cookies and similar technologies to enhance your experience, enabling functionalities such as:

  • Basic site functions
  • Ensuring secure, safe transactions
  • Secure account login
  • Remembering account, browser, and regional preferences
  • Remembering privacy and security settings
  • Analyzing site traffic and usage
  • Personalized search, content, and recommendations
  • Displaying relevant, targeted ads on and off IvyPanda

Please refer to IvyPanda's Cookies Policy and Privacy Policy for detailed information.

Required Cookies & Technologies
Always active

Certain technologies we use are essential for critical functions such as security and site integrity, account authentication, security and privacy preferences, internal site usage and maintenance data, and ensuring the site operates correctly for browsing and transactions.

Site Customization

Cookies and similar technologies are used to enhance your experience by:

  • Remembering general and regional preferences
  • Personalizing content, search, recommendations, and offers

Some functions, such as personalized recommendations, account preferences, or localization, may not work correctly without these technologies. For more details, please refer to IvyPanda's Cookies Policy.

Personalized Advertising

To enable personalized advertising (such as interest-based ads), we may share your data with our marketing and advertising partners using cookies and other technologies. These partners may have their own information collected about you. Turning off the personalized advertising setting won't stop you from seeing IvyPanda ads, but it may make the ads you see less relevant or more repetitive.

Personalized advertising may be considered a "sale" or "sharing" of the information under California and other state privacy laws, and you may have the right to opt out. Turning off personalized advertising allows you to exercise your right to opt out. Learn more in IvyPanda's Cookies Policy and Privacy Policy.

1 / 1